Creating new technologies to improve cancer treatment through gene modification.
Development of New Technologies at Roswell Park to Further Cancer-Based Research and Treatment Through Genome Modification
This study is exploring new ways to change genes to improve cancer treatments, and it's for anyone affected by cancer who hopes for better therapies in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Roswell Park Cancer Institute Corp NIH-funded |
| Lab location | 1 site (Buffalo, United States) |
| Project ID | NIH-10931670 on NIH RePORTER |
What this research studies
This research focuses on advancing cancer treatment by developing new technologies for genome modification. Led by Dr. Aimee Stablewski at Roswell Park Comprehensive Cancer Center, the project aims to enhance the capabilities of gene targeting and transgenic resources. By collaborating with various cancer researchers, the team will apply innovative genome editing techniques to better understand and treat different types of cancer. Patients may benefit from the insights gained through these advanced methodologies in future therapies.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research are individuals diagnosed with cancer who may be eligible for novel gene-targeted therapies.
Not a fit: Patients with non-cancerous conditions or those who do not meet the criteria for gene-targeted therapies may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments tailored to individual genetic profiles.
How similar studies have performed: Previous research in genome modification for cancer treatment has shown promising results, indicating that this approach has the potential for significant advancements.
Where this research is happening
Buffalo, United States
- Roswell Park Cancer Institute Corp — Buffalo, United States (Active)
Researchers
- Principal investigator: Stablewski, Aimee B — Roswell Park Cancer Institute Corp
- Study coordinator: Stablewski, Aimee B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.